Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2012 by Denver Research Institute.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
Paul Saenger, Denver Research Institute
ClinicalTrials.gov Identifier:
NCT00737256
First received: August 14, 2008
Last updated: September 6, 2012
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2014
  Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)